Kangmei Pharmaceutical Co., Ltd. (SHA:600518)
China
· Delayed Price · Currency is CNY 1.870
+0.010 (0.53%)
Mar 10, 2026, 10:05 AM CST
Kangmei Pharmaceutical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 25,860 | 32,441 | 25,787 | 30,501 | 42,839 | 13,330 | Upgrade
|
| Market Cap Growth | -20.96% | 25.81% | -15.46% | -28.80% | 221.38% | -28.15% | Upgrade
|
| Enterprise Value | 24,836 | 31,918 | 24,904 | 28,797 | 76,028 | 47,878 | Upgrade
|
| Last Close Price | 1.87 | 2.34 | 1.86 | 2.20 | 3.09 | 2.68 | Upgrade
|
| PE Ratio | 1554.05 | 3783.85 | 251.53 | - | 5.41 | - | Upgrade
|
| Forward PE | - | 2.56 | 2.56 | 2.56 | 2.56 | 2.56 | Upgrade
|
| PS Ratio | 4.90 | 6.25 | 5.29 | 7.30 | 10.32 | 2.46 | Upgrade
|
| PB Ratio | 3.58 | 4.50 | 3.64 | 4.37 | 4.30 | -1.28 | Upgrade
|
| P/TBV Ratio | 3.87 | 4.87 | 4.00 | 4.83 | 4.64 | - | Upgrade
|
| P/FCF Ratio | - | - | - | - | 1006.12 | 18.27 | Upgrade
|
| P/OCF Ratio | 431.71 | - | - | - | 199.99 | 12.92 | Upgrade
|
| PEG Ratio | - | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | Upgrade
|
| EV/Sales Ratio | 4.71 | 6.15 | 5.11 | 6.89 | 18.31 | 8.85 | Upgrade
|
| EV/EBITDA Ratio | - | - | 52.89 | - | - | - | Upgrade
|
| EV/EBIT Ratio | - | - | 138.67 | - | - | - | Upgrade
|
| EV/FCF Ratio | -641.52 | - | - | - | 1785.59 | 65.62 | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.02 | 0.04 | 0.04 | 0.02 | -2.09 | Upgrade
|
| Debt / EBITDA Ratio | 2.26 | - | 0.49 | - | - | - | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | 4.82 | 29.78 | Upgrade
|
| Net Debt / Equity Ratio | -0.15 | -0.12 | -0.11 | -0.18 | -0.22 | -2.03 | Upgrade
|
| Net Debt / EBITDA Ratio | 3576.03 | 6.36 | -1.70 | 1.70 | 0.89 | -0.81 | Upgrade
|
| Net Debt / FCF Ratio | 27.44 | 1.71 | 1.92 | 1.56 | -51.99 | 29.02 | Upgrade
|
| Asset Turnover | 0.38 | 0.37 | 0.33 | 0.27 | 0.17 | 0.11 | Upgrade
|
| Inventory Turnover | 1.65 | 1.76 | 1.54 | 1.26 | 0.91 | 1.57 | Upgrade
|
| Quick Ratio | 0.75 | 0.74 | 0.69 | 0.82 | 1.00 | 0.54 | Upgrade
|
| Current Ratio | 1.21 | 1.17 | 1.12 | 1.36 | 1.68 | 0.80 | Upgrade
|
| Return on Equity (ROE) | 0.27% | 0.17% | 1.47% | -31.78% | - | -607.26% | Upgrade
|
| Return on Assets (ROA) | -1.23% | -1.84% | 0.76% | -4.17% | -7.71% | -34.21% | Upgrade
|
| Return on Invested Capital (ROIC) | -1.80% | -2.28% | 2.80% | -15.42% | -31.95% | -83.93% | Upgrade
|
| Return on Capital Employed (ROCE) | -3.50% | -5.20% | 2.20% | -10.70% | -27.40% | -266.80% | Upgrade
|
| Earnings Yield | 0.06% | 0.03% | 0.40% | -8.81% | 18.48% | -233.19% | Upgrade
|
| FCF Yield | -0.15% | -1.51% | -1.62% | -2.62% | 0.10% | 5.47% | Upgrade
|
| Payout Ratio | 4.51% | 8.75% | - | - | 0.17% | - | Upgrade
|
| Buyback Yield / Dilution | 0.25% | -39.38% | 27.54% | -1.85% | -0.55% | -179.83% | Upgrade
|
| Total Shareholder Return | 0.25% | -39.38% | 27.54% | -1.85% | -0.55% | -179.83% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.